Hangzhou Jirui Technology Co., Ltd.

Hangzhou Jirui Technology Co., Ltd. was established in September 2018. It is an innovative biomedical enterprise specializing in the automatic synthesis platform of nuclear medicine molecular imaging tracer drugs, research and development, production and sales of radiopharmaceuticals. The company has set up a research and development team composed of high-level talents at home and abroad, such as Zhejiang University and UCLA. Relying on the R & D resources of the Key Laboratory of Medical Molecular Imaging of Zhejiang Province and the Key Laboratory of Biomedical Engineering of the Ministry of Education of Zhejiang University, based on the nuclear medicine industry, focusing on independent research and development, and cooperating with external cooperation models, in tumors, cardiovascular and cerebrovascular diseases, Neurodegenerative diseases and other fields have gradually created a full-chain development pattern integrating nuclear medicine molecular imaging tracer synthesis devices and nuclear medicine (diagnostic and therapeutic) R & D, production and sales.

The company has developed multiple sets of nuclear medicine molecular imaging tracer drug fully automatic synthesis platforms, which are modular, multifunctional, and easy to operate. They are suitable for high-throughput preparation of radioactive drugs with different synthesis paths and meet strict clinical quality control requirements. At the same time, various new nuclide labeled positron emission tomography tracers and new preparation processes have been successfully developed, such as [18F]-Safranamide,[18F]-FHBG, [18F]-MK9470 and others have significant application value in the mechanism research and diagnosis of major diseases such as tumors, cardiovascular and cerebrovascular diseases, and neurodegeneration. Forming an industrial layout with the design and manufacturing of automatic synthesis systems for radioactive drugs, as well as the research and development, design, and production of new PET tracers as the core competition.

As a fast-growing technology enterprise, the company's brand value is gradually formed in the field of nuclear medicine imaging. We will continue to uphold the core values of innovation, professionalism and responsibility, and continue to strive for excellence and contribute to the cause of human health. We welcome people with lofty ideals to join us and work together to build a better future.